Esperion Therapeutics Inc (ESPR)

36.69
NASDAQ : Health Care
Prev Close 37.38
Day Low/High 36.38 / 37.71
52 Wk Low/High 9.40 / 48.21
Avg Volume 2.18M
Exchange NASDAQ
Shares Outstanding 22.56M
Market Cap 843.14M
EPS -3.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ESPR Crosses Above Average Analyst Target

ESPR Crosses Above Average Analyst Target

In recent trading, shares of Esperion Therapeutics Inc have crossed above the average analyst 12-month target price of $36.25, changing hands for $36.79/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Biotech Premarket Movers: Esperion, Minerva and BioCryst

Biotech Premarket Movers: Esperion, Minerva and BioCryst

Esperion Therapeutics, Minerva Neurosciences and BioCryst Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.

How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More

How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More

Here's how to trade six of the most active names on the market this afternoon.

Biotechs Remain the Best Place For Stock Picking

Biotechs Remain the Best Place For Stock Picking

Biotech companies show more energy than the rest of the market Monday.

Biotech Premarket Movers: CytomX, Aevi, Esperion

Biotech Premarket Movers: CytomX, Aevi, Esperion

CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday.

AveXis, Esperion and Amgen Among Biotech Movers

AveXis, Esperion and Amgen Among Biotech Movers

AveXis, Esperion Therapeutics, Medicines Co. and Amgen were among the biotech stock movers Friday morning.

PaylPal, CH Robinson Worldwide, Texas Instruments: 'Mad Money' Lightning Round

PaylPal, CH Robinson Worldwide, Texas Instruments: 'Mad Money' Lightning Round

Jim Cramer is bullish on PaylPal, CH Robinson Worldwide, Texas Instruments and NXP Semiconductors.

Here's Why Buffett Is So Bullish About This Market: Cramer's 'Mad Money' Recap (Monday 2/27/17)

Here's Why Buffett Is So Bullish About This Market: Cramer's 'Mad Money' Recap (Monday 2/27/17)

Jim Cramer highlight's Buffett's confidence in American businesses and stocks, and his critique of high fees charged by money managers.

First Week of April 21st Options Trading For Esperion Therapeutics

First Week of April 21st Options Trading For Esperion Therapeutics

Investors in Esperion Therapeutics Inc saw new options become available this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ESPR options chain for the new April 21st contracts and identified one put and one call contract of particular interest.

Esperion Therapeutics Reaches Analyst Target Price

Esperion Therapeutics Reaches Analyst Target Price

In recent trading, shares of Esperion Therapeutics Inc have crossed above the average analyst 12-month target price of $17.10, changing hands for $17.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Premarket Biotech Movers: Portola, Esperion, Medicines

Premarket Biotech Movers: Portola, Esperion, Medicines

Portola Pharmaceuticals, Esperion Therapeutics and Medicines were among the biotech stock movers in premarket trading on Friday.

Notable Two Hundred Day Moving Average Cross - ESPR

Notable Two Hundred Day Moving Average Cross - ESPR

In trading on Wednesday, shares of Esperion Therapeutics Inc crossed below their 200 day moving average of $13.34, changing hands as low as $13.03 per share. Esperion Therapeutics Inc shares are currently trading off about 4.9% on the day.

Commit To Buy Esperion Therapeutics At $11, Earn 24.7% Annualized Using Options

Commit To Buy Esperion Therapeutics At $11, Earn 24.7% Annualized Using Options

Investors eyeing a purchase of Esperion Therapeutics Inc shares, but tentative about paying the going market price of $13.56/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June put at the $11 strike, which has a bid at the time of this writing of $1.20.

Esperion To Present At The 35th Annual J.P. Morgan Healthcare Conference

Esperion To Present At The 35th Annual J.P. Morgan Healthcare Conference

Presentation and Webcast on Tuesday, January 10, 2017 at 3:00 p.m. Pacific Time/6:00 p.m. Eastern Time

Bullish Two Hundred Day Moving Average Cross - ESPR

Bullish Two Hundred Day Moving Average Cross - ESPR

In trading on Monday, shares of Esperion Therapeutics Inc crossed above their 200 day moving average of $13.53, changing hands as high as $13.85 per share. Esperion Therapeutics Inc shares are currently trading up about 5.9% on the day.

ESPR: Insiders vs. Shorts

ESPR: Insiders vs. Shorts

The most recent short interest data was recently released for the 11/15/2016 settlement date, and Esperion Therapeutics Inc is one of the most shorted stocks of the Russell 3000, based on 8.69 "days to cover" versus the median component at 4.41. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.